Kavitha Bhasi

Director
C4 Therapeutics, Inc.

Poster(s):

• (M-095) Population Pharmacokinetics and Exposure-response Analysis of Cemsidomide in Patients with Relapsed/Refractory Multiple Myeloma and Non-Hodgkin’s Lymphoma
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT